Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The objective of this phase 2 study is to evaluate the safety and efficacy of HL-009
Liposomal Gel in adult patients with mild to moderate atopic dermatitis (AD).